SLU-PP-332 Price Comparison — Compare 6 Vendors
Price Comparison
Compare vendors
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| CertaPeptides7.5/10Out of stock | $317.83 | $6.36 | Jun 27, 2026 | Buy → |
| SomaChems7/10 | $59.99 | $6.67 | May 14, 2026 | Buy → |
| Glacier Aminos9.5/10 | $44.99 | $9.00 | Jun 23, 2026 | Buy → |
| Polar Peptides5/10 | $107.99 | $21.60 | Apr 17, 2026 | Buy → |
| Pinnacle Peptide Labs8/10 | $110.49 | $22.10 | Apr 23, 2026 | Buy → |
| Licensed Peptides8/10 | $129.99 | $519.96 | Jun 4, 2026 | Buy → |
Research details
SLU-PP-332 — research data
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Overview
About SLU-PP-332
Mechanism of action
Potent synthetic agonist of estrogen-related receptors α, β, and γ (ERRα/β/γ); activates mitochondrial biogenesis; enhances oxidative metabolism in muscle; mimics exercise adaptations.
Safety profile
Insufficient human data. Theoretical: hormonal disruption (ERR signaling), cardiovascular effects. Promising safety in animal studies. · Small-molecule ERR agonist, NOT a peptide. Never administered to a human — no trials, no human dose, human safety completely unknown. Animal safety was favorable, but the rating reflects zero human exposure. Lab reagent (DMSO-soluble).
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops SLU-PP-332 below your target.
Related pages
More on SLU-PP-332
Research
Studies & key findings
- SLU-PP-332 is a first-in-class synthetic pan-ERR agonist (ERRα EC50 = 98 nM, ERRβ 230 nM, ERRγ 430 nM) developed at Saint Louis University; in mice, 28-day administration increased type IIa oxidative skeletal muscle fibers and boosted treadmill endurance by ~70% in distance and ~45% in duration — effects shown to be ERRα-dependent via muscle-specific knockout validation.
- Mechanistically, SLU-PP-332 stabilizes the ERRα active conformation and recruits PGC-1α, inducing a transcriptional program overlapping with acute aerobic exercise — particularly upregulating mitochondrial biogenesis, fatty acid oxidation, and oxidative phosphorylation genes without requiring physical activity.